Two researchers at CEMIR, Atle Granlund and Richard Kandasamy have received the “Young Research Talents” – grants that is a part of the FRIPRO-funding (Norwegian link) for researchers early in their career. FRIPRO is an open, national competitive arena that covers all fields of research. It aims to promote scientific quality at the forefront of international research, boldness in scientific thinking and innovation, careers for young research talents and mobility for researchers early in their career. FRIPRO aims to contribute to strengthen Norway’s national knowledge base by funding broad-based, independent research, that is a prerequisite for all other research and is essential for future industrial development and for policymaking. Continue reading
Tag Archives: IKM
Blogger: Jane Atesoh Awuh, Postdoctoral Fellow, Department of Cancer Research and Molecular Medicine and Centre of Molecular Inflammation Research (SFF-CEMIR).
Most often we become passionate and involved in issues in this life for very personal reasons. I am particularly drawn to infectious diseases because I hail from a society that is plagued by one kind of infection or the other. If you are not killed by one infectious disease you will be by the other, and if not by disease, it will be by war or hunger. I know two relatives who died of tuberculosis, one of them only a couple of months ago. Tuberculosis (TB) is still a disease of poverty although there is increasing incidence even in developed countries. HIV and TB are a dangerous liaison wherein HIV infects and destroys the very cells that should protect us from TB. These diseases are still considered shameful and surrounded by stigma. Continue reading
Our innate immune system is the first and most important barrier of microbial threats such as viruses and bacteria. It will sense, and in most cases, clear out these pathogens – but not always. A new approach to studying macrophage response to viral threats have resulted in a vastly expanded knowledgebase of the dynamics of the host response to viral infection, and in turn how antiviral innate immunity works. The data is freely available at www.infectome-map.org. Continue reading
Blogger: Jimita Toraskar, Ph.D candidate at the Department of Cancer Research and
Molecular Medicine and a participant in Researchers Grand Prix 2016 and Tonje Strømmen Steigedal, researcher at the Department of Cancer Research and Molecular Medicine.
If you know the enemy and know yourself, you need not fear the result of hundred battles.
Breast cancer is that enemy, and we still don’t know everything about it. Every type of cancer is different and each breast cancer patient is unique. We all are haunted by one big question, ‘Have we solved the cancer problem’? But first, shall we take a moment to know our enemy better? Continue reading
Women with preeclampsia have up to eight times higher risk of later developing cardiovascular disease. CEMIR’s research group on Inflammation and Genetics in Pregnancy studies how the development of preeclampsia and cardiovascular disease are connected.
The group has recently unveiled inflammatory mechanisms in the placenta and identified an important role for fetal trophoblasts. They have also identified a gene variant that is protective for both preeclampsia and cardiovascular disease.
This research was recently presented at the International Society for the Study of Hypertension in Pregnancy (ISSHP), a conference about research and treatment of hypersensitive diseases during pregnancy, primarily preeclampsia and gestational hypertension.
Researcher Liv Cecilie Vestrheim Thomsen received the prize for best poster and Post.doc. Lobke Gierman received third place in the category best oral presentation.
Cholesterol crystals (CC) induce inflammation that is critical in the initiation and progression of atherosclerosis. Researchers at the Center of Molecular Inflammation Research (CEMIR) recently published new data on how high density lipoprotein attenuates inflammatory responses initiated by CC. These data could be of significant interest for management of atherosclerosis. Continue reading
Professor Harald Stenmark, has received this year’s “Møbius award”, the Research Council of Norway’s annual prize for excellent research. Stenmark is director of the Centre for Cancer Biomedicine at UIO and Professor II at the Centre of Molecular Inflammation Research, CEMIR.
The award is granted on the basis of documented results, and is intended to encourage further research activity. The award amounts to 1 mill. NOK and is distributed Wednesday September 23rd in Oslo Konserthus.
Congratulations to Professor Stenmark!
Some bacteria and viruses take advantage of the way our immune system works to infect us. Researchers at Centre of Molecular Inflammation Research (CEMIR) are uncovering the mechanisms by which this trickery takes place.
Read more on GEMINI.no: Uncovering the secrets of immune system invaders, written by Nancy Bazilchuk.
– Bruce Beutler’s work has greatly inspired scientists at NTNU, in particular researchers at Centre of Molecular Inflammation Research (CEMIR). We are very pleased that he has been awarded an honorary doctorate.
These were CEMIR director Terje Espevik’s words when Professor Bruce Beutler was awarded the degree of Doctor Honoris Causa (æresdoktor) at NTNU on 20th March 2015.
In December last year an outbreak of measles started when a family that was not vaccinated visited Disneyland California. I’m currently a visiting graduate student here in Los Angeles and I’d planned to go to Disneyland to get some of that Christmas magic-feeling that the decorated palm trees couldn’t convey.
I never went though. Before I even knew it Christmas had passed, January gone and nearly a hundred persons had been infected with measles after the outbreak that started in Disneyland.
… people who choose not to vaccinate their kids for religious or “personal reasons”
In the following months the disease spread and 2015 is expected to be a record year in the number of cases since measles was declared eradicated in the US in 2000. What I find especially aggravating is that measles are effectively prevented by vaccination and there is no cost involved. The vaccine is part of the vaccination program, as it is in Norway, yet there are several schools and kindergartens in California where dangerously few children are vaccinated. Their parents are mainly wealthy and well educated people who choose not to vaccinate their kids for religious or “personal reasons”. Parents need only a signature from a doctor or other type of health care provider to exempt their kid from vaccination and it seems like this signature is given out too easily.
The debate following the outbreak has to a large extent focused on parents right to choose and there is a strong tradition for valuing freedom of choice in the US. But when it comes to diseases such as measles, polio and whopping cough the parents that «feel vaccination is not for them» are putting more vulnerable individuals at risk. For herd immunity to be efficient against measles at least 95-97% of the population needs to be vaccinated. This is enough to prevent an outbreak and protect those who can’t be vaccinated due to health reasons, such as the very young or old, cancer patients or people with reduced immune function.